Plasma miR-323 as a Biomarker for Screening Papillary Thyroid Cancer From Healthy Controls

The present study aims to evaluate whether plasma miR-323 serves as a potential biomarker to screen patients with papillary thyroid cancer (PTC) from healthy controls. Real-time PCR was performed to evaluate miR-323 expression in healthy controls and benign thyroid nodule (BTN) and PTC patients. Rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yang, Li, Lin, Liu, Zheng, Yuan, Qingling, Lu, Xiubo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242560/
https://www.ncbi.nlm.nih.gov/pubmed/32478079
http://dx.doi.org/10.3389/fmed.2020.00122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242560/
https://www.ncbi.nlm.nih.gov/pubmed/32478079
http://dx.doi.org/10.3389/fmed.2020.00122

Ejemplares similares